Here & Now

We’re taking a closer look at the problem of housing affordability. Housing expert Christina Stacy answers questions we received in our inbox, and provides tips on renting and buying in this market. And, less than a tenth of people diagnosed with glioblastoma survive five years after diagnosis. That might change. German Biotech company CeGaT has developed a promising treatment for the deadly brain cancer by sequencing a unique vaccine from a patient’s cancer cells. We break down the process with Saskia Biskup, co-founder of CeGaT, and American patient Laura Eddington, who was joined by her husband, Jeff Eddington.See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.NPR Privacy Policy